BIO.News Newsletter

Patient advocates explain why they oppose MFN and BIO tells why it supports PAHPA. (979 words, 3 minutes, 55 seconds)

BIO’s CEO testifies in a hearing that highlights PBM abuses. Also, 52 conservative leaders oppose MFN in letter to Trump. (890 words, 3 minutes, 34 seconds)

BIO celebrates passage of PPRV reauthorization and PBM reform. Also, new legislation would help fight AMR. (943 words, 4 minutes, 42 seconds) Because Feb. 16 is Presidents Day, our next newsletter comes out Tuesday, Feb. 17.

BIO urges Congress to take concrete steps to strengthen U.S. biotechnology leadership. Plus, PPRV reauthorization and PBM reform return to the House for consideration. (872 words, 4 minutes, 21 seconds)

Lawmakers hone in on PBM problems. More good news about vaccines. (890 words, 4 minutes, 27 seconds)

An MFN proposal misses the mark. Plus, measles and flu rage while vaccination declines. (992 words, 4 minutes, 57 seconds)

BIO reacts to changed CDC vaccine recommendations. Plus a BIO initiative to support biotech investment. (746 words, 3 minutes, 43 seconds)

BIO’s Coffee Chat focused on why we need PPRV reauthorization. Plus, a year-end readers’ survey. (821 words, 4 minutes, 6 seconds) Bio.News will take a holiday break. The next newsletter is scheduled for Jan. 12. Happy holidays!

Please tell us what you think of Bio.News

The House passes pro-investment legislation backed by BIO. Plus, Bayh-Dole turns 45. (861 words, 4 minutes, 18 seconds)